Cara Therapeutics | CARA - PE Price to Earnings

Stock Price
3.64
Daily Change
0.05 1.39%
Monthly
-22.55%
Yearly
-75.59%
Q1 Forecast
3.53

Cara Therapeutics reported 27.77 in PE Price to Earnings for its fiscal quarter ending in September of 2021.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Chugai Pharma JPY 31.26 5.24 Dec/2025
Cipla INR 27.74 3.55 Dec/2025
Clal Biotechnology ILS 11.67 2.62 Dec/2022
CSL USD 25.74 6.38 Jun/2025
Grifols EUR 12.27 4.84 Sep/2025
Halozyme Therapeutics USD 23.16 7.7 Dec/2025
J&J USD 23.62 0.86 Dec/2025
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Pacira USD 29.24 6.15 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
RedHill Biopharma USD 0.04 0.03 Jun/2025
Supernus Pharmaceuticals USD 39.11 17.08 Sep/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023